Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01026779 · ClinicalTrials.gov registry record
Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island
A clinical trial of Rotavirus Gastroenteritis, sponsored by Lifespan.
- Completed
- Registry status
- 803
- Enrollment target
- 1
- Study location
NCT01026779 is a study of Rotavirus Gastroenteritis that has completed, run by Lifespan. The registered enrollment target is 803 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01026779, a study of Rotavirus Gastroenteritis, has completed, sponsored by Lifespan.
- COMPLETED
- Registry status
- 803 participants
- Enrollment target
- 1
- Study location
Study Summary
The goals of this study are to see what effects the introduction of RV5(RotaTeq) vaccine has had in the community both on the number of rotavirus-associated hospitalizations and on the strains of rotavirus circulating in the community. The investigators will use cases of rotavirus gastroenteritis identified on the wards at Hasbro Children's Hospital during the 2007-2009 rotavirus seasons for a case-control study to estimate rotavirus vaccine effectiveness in preventing rotavirus-associated hospitalizations. The investigators plan to assess rotavirus vaccine coverage in Rhode Island using the state vaccine registry and to examine whether and to what extent rotavirus vaccine was used outside the recommended age limits (off label) during the first 2 years of its implementation in Rhode Island. Finally using the state child health database, KIDSNET the investigators plan to investigate the reasons that children may not have received rotavirus vaccine in order to better target educational efforts for parents and health care providers.
Conditions Studied
Study Locations (1)
Rhode Island
- Hasbro Children's Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 803 participants |
| Start Date | 2009-07 |
| Est. Completion | 2019-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01026779
The ClinicalTrials.gov registry entry for NCT01026779 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 803 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lifespan, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rotavirus Gastroenteritis appearing as the primary indexed condition, and to 0 interventions.
NCT01026779 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.
Frequently Asked Questions
What is clinical trial NCT01026779 about?
NCT01026779 is a clinical study titled "Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island". The goals of this study are to see what effects the introduction of RV5(RotaTeq) vaccine has had in the community both on the number of rotavirus-associated hospitalizations and on the strains of rotavirus circulating in the community. The investigators will use cases of rotavirus gastroenteritis id...
What is the current status of trial NCT01026779?
This trial is currently completed. The enrollment target is 803 participants. The study started on 2009-07. Estimated completion is 2019-11-01.
What conditions does trial NCT01026779 study?
This clinical trial studies the following conditions: Rotavirus Gastroenteritis.
Who is sponsoring clinical trial NCT01026779?
This trial is sponsored by Lifespan, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01026779 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.